Cite
MLA Citation
Ester Simeone et al.. “Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients.” Journal for immunotherapy of cancer, vol. 3, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100135573669.0x000007